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NORMAL SKIN REACTIONS TO ULTRAVIOLET LIGHT
1. AN ATTEMPT TO MODIFY NORMAL ERYTHEMA AND PIGMENTATION WITH METHOXSALEN*
MILTON M. CAHN, M.D., EDWIN J. LEVY, M.D. AND BERTRAM SHAFFER, M.D.
Much has been written about the psoralens and
ultraviolet light (1). It has been suggested by
several iavestigators that suntanning may be
augmented through ingestion of 8-methoxy-
psoralen (2, 3) and that other responses of normal
human skin to solar radiation can be altered by
ingestion of these compounds (4).
The following experiments were devised to de-
termine the effect of ultraviolet light on the skin of
normal human volunteers taking mcthoxsalen
(8-methoxypsoralen). They were conducted dur-
ing the winter months using artificial sources and
again in the summer on clear sunny days between
10:00 A.M. and 2:00 P.M., when the subjects
were exposed to natural sunlight.
The sources of artificial radiation were as follows:
(1) A Westinghouse fluorescent sun-lamp,
emitting a continuous spectrum of rays,
2900—3500 A. U. (designated as the
FS4OT-12 lamp).
(2) A standard hot-quartz ultraviolet lamp
emitting a line spectrum with an intense
band at 2967 A. U.
(3) A Carbon-arc lamp ("C" carbon) emitting
a continuous spectrum.
In order to explore these effects more thoroughly,
various schedules of drug administration were
used in combination with the ultraviolet light ex-
posures from these different sources.
The ultraviolet light exposures also were varied
in their intensity and frequency of administra-
tion. Finally, various time relationships between
drug ingestion and ultraviolet light exposure were
employed.
Erythema resulting from ultraviolet light ex-
posures within the sunburn spectrum is graded
usually as 1+, 2+, 3+ and 4+.
1 + Erythema is barely perceptible erythema.
The amount of exposure required to produce a 1+
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erythema 24 hours after exposure is designated as
the minimal erythema dose (M.E.D.)
4 + erythema is the vivid maximal degree
crythema produced by an ultraviolet light ex-
posure. The least amount of exposure required to
produce a 4 + erythema, 24 hours after exposure,
is designated as the "minimal 4 + erythcma
dose."
Increased exposure beyond the minimal 4 +
crythema dose does not alter the degree of visible
erythema, but may result in increased inflam-
matory reaction manifested by edema and
vesiculation.
Intermediary grades, 2 + and 3 + erythema,
were estimated.
All erythema readings were made independ-
ently by two observers.
EXPERIMENT 1
Purpose
To determine the effect of a single dose of
mcthoxsalen on the minima] erythema dose of
ultraviolet light from artificial sources.
Method
Thirty (30) normal healthy white males re-
ceived graded exposures of the rays from a carbon
arc lamp ("C" carbon) and a Westinghouse
fluorescent sun-lamp (F540T12) to test sites on
the back, to determine the minimal crythema
dose (MED) for each subject. These readings
were graded visually.
Twenty (20) of these individuals were given a
single dose of methoxsalen. Five men received
5 mg.; 5 received 10 mg.; 5 received 20 mg. and
5 received 40 mg. The other ten (10) subjects re-
ceived placebo medication.
The minimal erythema dose was determined
again for each subject on different test sites 2
hours after drug ingestion and again 24 hours
later.
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Results
A single dose of methoxsalen did not change
the amount of ultraviolet light required to pro-
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duce minimal erythema in any subject in this
group.
EXPERIMENT #2
Purpose
To determine the effect of repeated doses of
methoxsalen on the minimal erythema dose of
ultraviolet light, from artificial sources.
Method
Thirty (30) normal healthy white males re-
ceived graded exposures of the rays from a carbon
are lamp ("C" carbon) and a fluorescent sun-
lamp (FS4OT12) to test sites on the back. The
MED for each individual was determined as in
experiment I.
Twenty (20) subjects received methoxsalen
daily for one month. Five received 5 mg. daily; 5
received 10 mg.; 5 received 20 mg. and 5 received
40 mg. The MED was determined each week on
different skin sites for the four weeks that the drug
was administered, and also each week for the next
four weeks.
Ten (10) subjects served as controls and were
given placebo tablets. They received the same
ultraviolet light exposures as received by subjects
taking methoxsalen.
Results
Repeated doses of methoxsalen did not alter
the amount of ultraviolet light required to pro-
duce minimal erythema in any subject in this
group.
EXPERIMENT #3
Purpose
To determine the effect on erythema and pig-
mentation of methoxsalen administered daily
with subsequent daily ultraviolet light exposures
from artificial sources.
Method
The MED was determined for 30 normal
healthy wbite males using a carbon arc lamp and
a fluorescent sun-lamp. Twenty (20) of these indi-
viduals received methoxsalen daily for one week
in the following amounts: 5 received 5 mg. daily;
5 received 10 mg.; 5 received 20 mg. and S re-
ceived 40 mg. The remaining 10 subjects were
given placebo medication. Each day, two hours
after drug or placebo ingestion, a minimal
TABLE I ExPERIMENT #3
Daily dosage of inethoxsaten
Degree of
Pigmenta-
tion
S mg. 10 mg. 20 mg. 40 mg. Placebo
0 1
+1 2 2 2
+2 2 3 2 3
+3 1 3 2 3
+4 1 1 2
Degree of pigmentation resulting from repeated
exposures of ultraviolet light to the same skin site.
(Figures indicate the number of subjects receiving
drug dose indicated).
erythema exposure was given to the same 5 cm.
square area of the upper back.
At the end of the week, the minimal erythema
dose also was determined on a skin site NOT pre-
viously exposed to the artificial light sources dur-
ing the course of this experiment.
Results
(1) Repeated daily minimal erythema ex-
posures of ultraviolet light to the same skin site
did not produce significant differences in the
erythema reaction in subjects taking methoxsalen
as compared with the control group.
(2) Repeated daily minimal erythema ex-
posures of ultraviolet light to the same skin site
produced intense pigmentation in some indi-
viduals and lesser degrees of pigmentation in
others. These gradations of pigmentation oc-
curred whether the subject received placebo, or
methoxsalen, and appeared to be unaffected by
methoxsalen ingestion. (table I).
(3) There was no alteration in the minimal
erythema dose in a previously unexposed site
either in subjects receiving m.ethoxsalen or in con-
trol subjects.
(4) There was no correlation between the de-
gree of pigmentation in the site not previously ex-
posed in individuals receiving varying doses of
methoxsalen, or placebo.
EXPERIMENT #4
Purpose
To determine the effect of repeated doses of
methoxsalen on the minimal erythema dose of
ultraviolet light, from natural sunlight.
This experiment duplicated Experiment #2,
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with the exception that summer sunlight during
June and July was used as the source of ultra-
violet light.
Results
No change was observed in the minimal ery-
thema dose. in any of the subjects in this group.
EXPERIMENT #5
Purpose
To determine the effects on erythema and pig-
mentation, of methoxsalen administered daily,
with subsequent daily minimal erythema ex-
posures of light to the same site from natural sun-
light. This was a repetition of Experiment #3,
using natural summer sunlight instead of artificial
light sources.
Results
The findings were comparable to those in Ex-
periment $3.
EXPERIMENT #6
Purpose
To determine the effect of daily sunlight ex-
posures for 7 days during July, in subjects taking
methoxsalen daily.
Method
Twenty (20) subjects received methoxsalen
each day in the following amounts: 5 received 5
mg.; 5 received 10 mg.; 5 received 20 mg. and 5
received 40 mg. Ten control subjects received
placebo.
All were given 45 minute daily mid-day sun-
light exposures to the anterior abdominal wall.
Results
There was no significant correlation between
the amount of erythema and pigmentation ob-
served in subjects receiving various amounts of
methoxsalen or p]acebo, when they were exposed
to natural sunlight daily for one week, (table II).
EXPERIMENT $7
Purpose
To determine the effect of a single dose of
methoxsalen on erythema and pigmentation when
reexposed to sunlight, 1 month after initial ex-
posure.
Twenty (20) men received a single dose of
TABLE II
Results after one week of daily exposure to sunlight
in patients taking medication for one week
Subject
1
2
3
4
5
5mg.
5mg.
5mg.
5mg.
5mg.
Erythema Pigmenta-
3+ 3+
1+ 3+
1+ 3+
2+ 2+
1+ 1+
6
7
8
9
10
10mg.
10mg.
10mg.
10mg.
10 mg.
—
4+
4+
2+
1+
2+
1+
2+
1+
2+
11
12
13
14
15
16
17
18
19
20
20mg.
20 mg.
20 mg.
20mg.
20 mg.
40mg.
40mg.
40 mg.
40 mg.
40mg.
—
4+
3+
1+
2+
4+
4+
3+
1+
—
1+
1+
2+
1+
3+
—
1+
2+
3+
3+
21
22
23
24
25
26
27
28
29
30
Placebo
Placebo
Placebo
Placebo
Placebo
Placebo
Placebo
Placebo
Placebo
Placebo
3+
1+
—
4+
1+
1+
—
2+
4+
1+
1+
1+
1+
1+
2+
3+
1+
3+
1+
2+
methoxsalen (5 received 5 mg.; S received 10 mg.;
5 received 20 mg.; 5 received 40 mg.). Ten (10)
men served as controls and received a single dose
of placebo. Two and half hours later, one-half of
the abdomen of each subject was exposed to a 4 +
erythema dose of sunlight. Further exposures to
sunlight were not permitted.
One month later the pigmentation on this pre-
viously exposed area was recorded. Then, the
entire abdomen of each subject was exposed to a
4 + erythema dose of sunlight. The results were
observed the following day and again one month
later.
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Results
(1) Although each subject developed an initial
4 + erythema on the test side, one month later
different amounts of residual pigmentation were
noted in various subjects ranging from 0 to 4 +
both in the placebo group and the drug treated
group. However, there was no correlation between
the degree of pigmentation remaining, and the
initial dosage of methoxsalen or the placebo.
(2) Although reexposure of the entire abdomen
of each subject resulted in a 4 + erythema on the
previously unexposed side, the degrees of cry-
thema produced on the previously exposed side
varied from 0 to +4, with no correlation between
the erythema produced in the placebo treated
group as compared to the drug treated group.
There was also no correlation between the degree
of erythema and dose of methoxsalen.
EXPERIMENT 8
Purpose
To determine the effect of daily 4 + erythema
doses of sunlight in patients taking methoxsalen
daily for one week.
Method
Twenty (20) men received methoxsalen daily
for one week (5 received 5 mg.; 5 received 10 mg.;
5 received 20 mg.; 5 received 40 mg.). Ten (10)
men served as controls and received a daily dose
of placebo.
All subjects received a 4 + erythema exposure
from sunlight 2j. hours after ingestion of the
medication, to one half of the abdomen each day
during the week they were taking the medication.
One month later, the pigmentation on this previ-
ously exposed area was noted. Then the entire
abdomen of each subject was exposed to a 4+
erythema dose of sunlight. Results were read 24
TABLE III
Effect of sunlight on skin of patients taking single
large dose 50 mg. of methoxsaten
Intense Sunburn Reactioo (4+)
Mild to Moderate
Sunburo Reaction(1+ to 3+)
Number of
subjects
Placebo
3
St mg.
methox-
saleo
4
Placebo
12
50 mg.
metbox-
saleo
11
hours after the last dosage of medication and one
month later.
Results
Although each subject developed a 4 + cry-
thema reaction following the first dose of methox-
salen or placebo, the subsequent erythema reaction
and pigmentation varied from subject to subject,
over a period of 7 days during which time the
medication was being administered. The intensity
of the erythema reaction and pigmentation were
such as to preclude any correlation between the
experimental and the control group. The cry-
thema and pigmentation reactions which ap-
peared following the sunlight exposure given one
month later showed different degrees of reactivity
which could not be related to either placebo or
drug ingestion.
EXPERIMENT fl
Purpose
To determine the effect of sunlight on the skin
of patients taking a single large dose (50 mg.) of
methoxsalen.
Method
Fifteen (15) men received a single 50 mg. dose
of methoxsalen, and 15 received placebo medica-
tion. Two and one-half (2}) hours after drug in-
gestion, the abdomen of each was exposed to 3
hour of strong sunlight.
Results
The administration of a single large dose of
methoxsalen produced an erythema reaction
which did not differ significantly from a com-
parably exposed placebo group, (table III).
EXPERIMENT 10
Purpose
To determine the effectiveness of methoxsaien
in protecting the skin from ultraviolet light
"burn", using an artificial light source.
Method
The minimal exposure of ultraviolet light from
an FS4O-12 lamp required to produce a 4 + cry-
thema response was determined for each of 50
men.
Thirty (30) men received 30 mg. of methox-
salen, and 20 men received placebo medication.
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TABLE IV
Clinical reactions in patients from whom biopsy specimens were taken. (Exp. 10)
.
Sub3ect Medication
Pigmentation Degree of Erythema
Remaining in 24 Hours After 4+
Previously Exposed Erythema Exposure toSide I Month After Previously Exposed
Exposure Half of Abdomen
Degree of Eiythema
24 Hours. After 4+
Erythema Exposure to
Previously Unexposed
Half of Abdomen
Comment
1 Placebo 0 0 4+ Previously exposed half
protected from further
burn.
2 Placebo 3+ 0 4+ Previously exposed half
protected from further
burn.
3 Methoxsalen
(30 mg.
2+ 0 4+ Previously exposed half
protected from further
burn.
4 Methoxsalen
(30 mg.)
4+ 0 4+ Previously exposed half
protected from further
burn.
5 Placebo 4+ 0 4+ Previously exposed half
protected from further
burn.
6 Placebo 2+ 4+ 4+ Previously exposed side
not protected.
7
8
Methoxsalen
(30 mg.)
Methoxsalen
(30 mg.)
2+
1+
4+
4+
4+
4+
Previously exposed side
not protected.
Previously exposed side
not protected.
Two hours later a 4 + erythema exposure was ad-
ministered to half the abdomen of each subject.
Thereafter each man received this medication
with exposure to the same half of the abdomen
daily for a total of 7 days.
Four weeks later, a 4 + erythema exposure was
given to the entire abdomen. Two biopsy speci-
mens (one from each side of the abdomen) were
obtained from each of eight (8) subjects. These 8
were selected from the total group of 50 men since
they illustrated the variations in the clinical re-
actions which were noted in the total group,
(table IV).
Results
(I) Although all subjects developed a 4 + cry-
thema on the previously unexposed side of the
abdomen, the previously exposed side showed
varying degrees of erythema from 0 to 4 + of such
a distribution as to indicate that there was no
correlation between the degree of protection and
the ingestion of methoxsalen or placebo (table V).
(2) Patients who ingested psoralens and were
exposed to ultraviolet light did not develop more
thickening of the stratum corneum nor did they
Medication and
nose
Number
of
Subjects
CompleteProtec-
tion
Partial
Protec-
tb,,
No Pro-
tection
Methoxsalen 30 18 5 7
30 mg.
Placebo 20 14 2 4
have more melanocytic activity or pigment re-
tention in the supra-basilar layers of the epidermis
than non-psoralen, ultraviolet light exposed pa-
tients. The details of this study will be presented
in another paper.
DISCUSSION
There were a total of 328 subj ects used in these
experiments; 208 were experimental (active medi-
cation) cases and 120 were controls (placebo medi-
cation). These subjects were given doses of
TABLE V
Degree of protection from "burn" (Exp. 10)
(Complete protection = no visible erythema
partial protection = 1+ or 2+ erythema; no pro-
tection = 3+ or 4+ erythema.)
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medication and doses of ultraviolet radiation
(both artificial and natural) covering various pos-
sible clinical contingencies. In not one group
could it be demonstrated that methoxsalen
possessed any regular effect in influencing the ery-
thema or pigmentary reactions of the skin.
Based on the observations of many physicians
it is possible that methoxsalen may produce pro-
nounced erythema reactivity in an occasional pa
tient, but if this is so, it must be quite unusual,
because our investigations failed to turn up such a
result in a significant number of cases. In all we do
not feel that methoxsalen can be depended upon
to influence erythema production, pigmento-
genesis, or to produce increased tolerance to
ultravoilet light exposure.
The effect of ultraviolet light on normal human
skin is well known. Following exposure to the sun-
burn radiations (2900—3100 A) there is a latent
period which ends with the appearance of cry-
thema and subsequent pigmentation. These re-
actions vary in degree in different individuals
Even a small exposure may suffice at times to
protect some persons from further burn for many
months, though no increased pigmentation is
clinically apparent.
Not only are there variations in reactions to
ultraviolet light in different individuals but even
the same individual exhibits different responses on
different parts of the skin or on the same part of
the skin at different times.
These individual differences in response to
ultraviolet light exposure make experimental
results difficult to interpret. However, the use of
sufficient numbers of experimental and control
subjects provides a better basis for the evaluation
of these reactions and we believe it also will re-
solve the apparently conflicting reports of various
investigators.
Melanin formation is not an essential but an
accessory factor in ultraviolet protection. We
agree with Fitzpatrick and Szabo (5), that "on
the basis of our present knowledge, it is not pos-
sible to assign relative values to the stratum
eorneum and malanin as biological ultraviolet
filters". The mechanism involved in protection
acquired by repeated exposures of ultraviolet
light is not yet known.
SUMMARY AND CONCLUSIONS
(1) No alteration was observed in the amount
of ultraviolet light, either from artificial or
natural sources, required to produce minimal cry-
thema in psoralen treated subjects as compared
to placebo treated controls.
(2) Methoxsalen ingestion neither inhibited
nor enhanced sunburn erythema or pigmentation.
(3) There were no consistent histologic differ-
ences in the skin of subjects taking methoxsalen,
versus placebo, either in sunburned or in pig-
mented areas.
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